These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3668575)

  • 1. Movement disorder associated with abnormal copper metabolism and decreased blood antioxidants.
    Pall HS; Williams AC; Blake DR; Winyard P; Chirico S; Brailsford S
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1234-5. PubMed ID: 3668575
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic pathways of red blood cell copper in normal humans and in Wilson's disease.
    Neumann PZ; Silverberg M
    Nature; 1967 Feb; 213(5078):775-9. PubMed ID: 6031801
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning].
    Deng SL; Li XF; Guo XL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the serum copper-oxidase activity in 8 families affected by Struempell-Wilson disease (hepatolentricular degeneration)].
    GIAGHEDDU M; CHESS-PERLE E
    Sist Nerv; 1961; 13():237-52. PubMed ID: 13898276
    [No Abstract]   [Full Text] [Related]  

  • 7. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 8. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Copper-induced hemolysis in Wilson's disease].
    Tönz O; Furrer HU; Bangerter U
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1800-2. PubMed ID: 5140922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 11. [Abnormal platelet function in Wilson's disease].
    Cohen AM; Creter D; Klein B; Lewinski UH; Djaldetti M
    Harefuah; 1982 Sep; 103(5-6):101-2. PubMed ID: 7169171
    [No Abstract]   [Full Text] [Related]  

  • 12. Interrelation between structure and protective action of normal and pathological ceruloplasmins during copper-induced lysis of red blood cells.
    Saenko EL; Skorobogat'ko OV; Yaropolov AI
    Biochem Int; 1990 Nov; 22(4):749-57. PubMed ID: 1964048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The content of copper in the blood serum in normal subjects and in patients with various diseases of the brain].
    GEKHT BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1961; 61():707-12. PubMed ID: 13704239
    [No Abstract]   [Full Text] [Related]  

  • 14. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathobiochemistry of Wilson's disease].
    Biesold D; Lössner J; Bachmann H; Zotter J
    Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 17. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Sintusek P; Dhawan A
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26690865
    [No Abstract]   [Full Text] [Related]  

  • 18. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Iorio R; Ranucci G
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26863385
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems of hemolysis in Wilson's disease].
    Czlonkowska A
    Neurol Neurochir Pol; 1972; 6(5):879-83. PubMed ID: 4571815
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatolenticular degeneration complicated with acute hematolysis and acute liver failure: report of one case].
    Xu CR; Yang Z; Rao RC
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1160, 1168. PubMed ID: 14669749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.